Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Cilnidipine/Valsartan Combination in Healthy Males
NCT02088008Phase 1Unknown
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- May 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cilnidipine and valsartan in hypertension (HTN) (2 arms), sponsored by Ildong Pharmaceutical Co Ltd. Primary endpoints: Area Under the Curve to the last measurable concentration and Maximum Plasma Concentration. Status: unknown.
02
Drugs
cilnidipinevalsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02088008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02088008.